I think we're going to see a lot of this kind of deal...the big companies will be spending money to buy other companies in order to get something in the pipeline...
LONDON/ZAGREB Feb 14 (Reuters) - Europe's biggest drugmaker, GlaxoSmithKline Plc, said on Tuesday it had bought the research institute of Croatian drug maker Pliva in a deal worth up to $50 million.
Pliva will receive an upfront sum of $35 million with possible further payments of up to $15 million depending on the entry of certain early stage projects into clinical development.
Pliva will also receive royalties on certain experimental drugs if they reach the market.
link to full Reuters artcile
Tuesday, February 14, 2006
Glaxo buys Pliva's R&D drug unit in $50 mln deal
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment